Peter W. Mullen
Impact in
-
- Pharmacological Effects and Toxicity Studies
- Pharmaceutical studies and practices
- Psychiatry and Mental health top 10%
- Epilepsy research and treatment
Papers in
-
- Pharmacological Effects and Toxicity Studies 7
- Pharmaceutical studies and practices 6
-
- RNA Interference and Gene Delivery 2
- Enzyme function and inhibition 2
- Co-authors
- A. Richens (2 shared papers)J Wadsworth (2 shared papers)B. Rambeck (2 shared papers)S. B. Lucas (1 shared paper)G. E. Mawer (1 shared paper)Takashi Ishizaki (1 shared paper)Hisao Miura (1 shared paper)Lewis B. Sheiner (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (2 papers)Biochemical Pharmacology (1 paper)Clinical Chemistry (1 paper)Clinical Pharmacokinetics (1 paper)Therapeutic Drug Monitoring (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Peter W. Mullen
15 papers receiving 332 citations
Peers
Comparison fields: 5 of 85
- Pediatrics, Perinatology and Child Health 209
- Psychiatry and Mental health 107
- Pharmacology 60
- Anesthesiology and Pain Medicine 25
- Pharmacology 82
Countries citing papers authored by Peter W. Mullen
This map shows the geographic impact of Peter W. Mullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Mullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Mullen more than expected).
Fields of papers citing papers by Peter W. Mullen
This network shows the impact of papers produced by Peter W. Mullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Mullen. The network helps show where Peter W. Mullen may publish in the future.
Co-authors
The 17 scholars most cited alongside Peter W. Mullen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 90 | |
| 2 | 1978 | 54 | |
| 3 | 1978 | 51 | |
| 4 | 1974 | 46 | |
| 5 | 1979 | 45 | |
| 6 | 1979 | 28 | |
| 7 | 1977 | 13 | |
| 8 | 1980 | 12 | |
| 9 | 1992 | 11 | |
| 10 | 1977 | 10 | |
| 11 | 1957 | 8 | |
| 12 | 1974 | 4 | |
| 13 | 1979 | 2 | |
| 14 | 1979 | 1 | |
| 15 | Pharmacokinetics of phenytoin and liver cytochrome P-450 levels in mice after single doses of Corynebacterium parvum [proceedings]. | 1979 | 1 |
| 16 | 1972 | 1 | |
| 17 | Immunotoxicology: A Current Perspective of Principles and Practice | 2011 | 0 |
About Peter W. Mullen
Peter W. Mullen is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology, Psychiatry and Mental health, Pharmacology and Oncology, having authored 17 papers that have together received 377 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (7 papers), Pharmaceutical studies and practices (6 papers), Epilepsy research and treatment (4 papers), Pharmacogenetics and Drug Metabolism (2 papers), Drug Transport and Resistance Mechanisms (2 papers), RNA Interference and Gene Delivery (2 papers), HIV Research and Treatment (2 papers) and Enzyme function and inhibition (2 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (209 citations), Psychiatry and Mental health (107 citations), Pharmacology (60 citations), Anesthesiology and Pain Medicine (25 citations) and Pharmacology (82 citations). Peter W. Mullen has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include A. Richens, J Wadsworth, B. Rambeck, S. B. Lucas, G. E. Mawer, Takashi Ishizaki, Hisao Miura, Lewis B. Sheiner, Kazuhiro Chiba and Kimio Minagawa. Their work appears in journals such as British Journal of Clinical Pharmacology, Biochemical Pharmacology, Clinical Chemistry, Clinical Pharmacokinetics and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.